arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Filana Therapeutics, Inc.

FLNA Health Care Biotechnology: Pharmaceutical Preparations
$0.83
▲ +1.2% Today
as of Sep 4, 16:49 ET
Last 30 days -6.82% Jul 28 → Sep 04
$0.80 $0.86 $0.92 $0.99 $1.05 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$0.82
High
$0.85
Low
$0.80
Volume
$285,230
Avg Vol
$1M
Mkt Cap
$46M
P/E (TTM)
Beta
52w High
$4.98
52w Low
$0.80
Div Yield
Shares Out
$48M

Recent Press Releases & News last 60 days · 1 item

Overview

52-week range
$0.80
$4.98
1% of range
Avg surprise (last 0)
Avg reaction (last 2)
+1.7%
50% positive
Latest IV / EM
2224%
EM ±347.5% · $3 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.63$-0.44$-0.25$-0.06$0.13 Actual $-0.58Actual $-0.63Actual $-0.61Actual $-0.43Actual $0.13Actual $-0.58Actual $-0.48Actual $-0.18Actual $-0.22Actual $-0.21 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026
Revenue vs Net Income Revenue Net income
$-44M$-32M$-19M$-6M$6M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.21 +56.2% -5.6% earnings
Tue Sep 30, 2025Sep 2025 $-0.22 financials
Thu Aug 14, 2025Jun/2025 $-0.18 earnings
Thu May 8, 2025Mar/2025 $-0.48 +9.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.58 financials
Sun Jun 30, 2024Jun 2024 $0.13 financials
Sun Mar 31, 2024Mar 2024 $-0.43 financials
Sat Sep 30, 2023Sep 2023 $-0.61 financials
Fri Jun 30, 2023Jun 2023 $-0.63 financials
Fri Mar 31, 2023Mar 2023 $-0.58 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-11M$-12M$-45M$-25M$-31M$-61M
Net income$-10M$-11M$-44M$-23M$-28M$6M
EPS (diluted)$-0.22$-0.92$-0.48$-0.58$0.13

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$87M$96M$106M$112M$117M$129M$149M$207M
Inventory
Total current assets$88M$98M$109M$115M$120M$137M$203M$222M
Total assets$108M$118M$130M$135M$141M$158M$224M$244M
Long-term debt
Total liabilities$40M$44M$48M$47M$13M$12M$57M
Total equity$68M$74M$82M$88M$128M$146M$167M$189M

Implied volatility — last 90 days

82%2609%5137%7664%10191% Jun 07 — IV 2817% · EM ±390.2%Jun 08 — IV 2727% · EM ±360.1%Jun 09 — IV 2895% · EM ±362.7%Jun 10 — IV 3303% · EM ±390.2%Jun 11 — IV 3504% · EM ±387.2%Jun 12 — IV 4027% · EM ±412.0%Jun 15 — IV 5884% · EM ±425.6%Jun 16 — IV 7147% · EM ±422.1%Jun 17 — IV 10191% · EM ±425.6%Jun 22 — IV 997% · EM ±208.2%Jun 23 — IV 1006% · EM ±205.9%Jun 24 — IV 1121% · EM ±224.6%Jun 29 — IV 993% · EM ±176.0%Jun 30 — IV 1196% · EM ±205.9%Jul 01 — IV 1317% · EM ±220.0%Jul 02 — IV 1261% · EM ±204.0%Jul 03 — IV 1327% · EM ±207.3%Jul 06 — IV 1531% · EM ±212.0%Jul 07 — IV 1485% · EM ±196.2%Jul 09 — IV 1956% · EM ±231.1%Jul 10 — IV 2071% · EM ±228.8%Jul 13 — IV 2915% · EM ±243.5%Jul 14 — IV 3488% · EM ±252.3%Jul 15 — IV 2848% · EM ±168.2%Jul 16 — IV 6333% · EM ±264.5%Jul 20 — IV 83% · EM ±19.6%Jul 21 — IV 85% · EM ±19.8%Jul 22 — IV 136% · EM ±31.1%Aug 10 — IV 145% · EM ±20.1%Aug 11 — IV 156% · EM ±20.6%Aug 12 — IV 128% · EM ±16.1%Aug 24 — IV 1539% · EM ±321.3%Aug 25 — IV 1545% · EM ±316.2%Aug 26 — IV 1390% · EM ±278.5%Aug 27 — IV 1632% · EM ±319.6%Aug 28 — IV 1715% · EM ±328.3%Aug 31 — IV 1634% · EM ±289.5%Sep 01 — IV 1897% · EM ±326.6%Sep 02 — IV 1850% · EM ±309.0%Sep 03 — IV 2127% · EM ±344.1%Sep 04 — IV 2224% · EM ±347.5%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.